Carnevali Davide, Zhong Limei, González-Almela Esther, Viana Carlotta, Rotkevich Mikhail, Wang Aiping, Franco-Barranco Daniel, Gonzalez-Marfil Aitor, Neguembor Maria Victoria, Castells-Garcia Alvaro, Arganda-Carreras Ignacio, Cosma Maria Pia
Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Nat Mach Intell. 2024;6(9):1021-1033. doi: 10.1038/s42256-024-00883-x. Epub 2024 Aug 27.
Cellular phenotypic heterogeneity is an important hallmark of many biological processes and understanding its origins remains a substantial challenge. This heterogeneity often reflects variations in the chromatin structure, influenced by factors such as viral infections and cancer, which dramatically reshape the cellular landscape. To address the challenge of identifying distinct cell states, we developed artificial intelligence of the nucleus (AINU), a deep learning method that can identify specific nuclear signatures at the nanoscale resolution. AINU can distinguish different cell states based on the spatial arrangement of core histone H3, RNA polymerase II or DNA from super-resolution microscopy images. With only a small number of images as the training data, AINU correctly identifies human somatic cells, human-induced pluripotent stem cells, very early stage infected cells transduced with DNA herpes simplex virus type 1 and even cancer cells after appropriate retraining. Finally, using AI interpretability methods, we find that the RNA polymerase II localizations in the nucleoli aid in distinguishing human-induced pluripotent stem cells from their somatic cells. Overall, AINU coupled with super-resolution microscopy of nuclear structures provides a robust tool for the precise detection of cellular heterogeneity, with considerable potential for advancing diagnostics and therapies in regenerative medicine, virology and cancer biology.
细胞表型异质性是许多生物学过程的一个重要标志,而了解其起源仍然是一项重大挑战。这种异质性通常反映了染色质结构的变化,受病毒感染和癌症等因素影响,这些因素会极大地重塑细胞格局。为应对识别不同细胞状态的挑战,我们开发了细胞核人工智能(AINU),这是一种深度学习方法,能够在纳米级分辨率下识别特定的核特征。AINU可以根据超分辨率显微镜图像中核心组蛋白H3、RNA聚合酶II或DNA的空间排列来区分不同的细胞状态。仅用少量图像作为训练数据,经过适当再训练后,AINU就能正确识别人类体细胞、人类诱导多能干细胞、用1型单纯疱疹病毒DNA转导的极早期感染细胞,甚至癌细胞。最后,使用人工智能可解释性方法,我们发现核仁中的RNA聚合酶II定位有助于区分人类诱导多能干细胞与其体细胞。总体而言,AINU与核结构的超分辨率显微镜相结合,为精确检测细胞异质性提供了一个强大工具,在推进再生医学、病毒学和癌症生物学的诊断与治疗方面具有巨大潜力。